Comparative study of ELLIPTA dry powder inhaler (DPI) versus DISKUS DPI used with HandiHaler DPI in subjects with Chronic Obstructive Pulmonary Disease (COPD)

Trial Identifier: 206901
Sponsor: GlaxoSmithKline
NCTID:: NCT03227445
Start Date: September 2017
Primary Completion Date: January 2018
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, Florida Orlando, Florida, United States, 32825
United States, Louisiana Natchitoches, Louisiana, United States, 71457
United States, Missouri St. Charles, Missouri, United States, 63301
United States, North Carolina Charlotte, North Carolina, United States, 28207
United States, North Carolina Gastonia, North Carolina, United States, 28054
United States, North Carolina Monroe, North Carolina, United States, 28112
United States, North Carolina Mooresville, North Carolina, United States, 28117
United States, Ohio Canton, Ohio, United States, 44718
United States, Ohio Cincinnati, Ohio, United States, 45231
United States, Ohio Dayton, Ohio, United States, 45419
United States, Oklahoma Oklahoma City, Oklahoma, United States, 73120
United States, Oregon Medford, Oregon, United States, 97504
United States, South Carolina Anderson, South Carolina, United States, 29621
United States, South Carolina Greenville, South Carolina, United States, 29615
United States, South Carolina Rock Hill, South Carolina, United States, 29732
United States, South Carolina Spartanburg, South Carolina, United States, 29303
United States, Virginia Richmond, Virginia, United States, 23225
United States, Virginia Richmond, Virginia, United States, 23229